Lista de obras - Sue O'Dorisio - Dominio Público Uruguay

"Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system

scientific article published on January 2013

2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells

artículo científico publicado en 2010

90Y-edotreotide for metastatic carcinoid refractory to octreotide

artículo científico publicado en 2010

A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon

artículo científico publicado en 2003

Age-dependent levels of plasma neuropeptides in normal children

artículo científico publicado en 2002

Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children

artículo científico publicado en 2008

Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling

artículo científico publicado en 2012

Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment

artículo científico publicado en 2004

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

artículo científico publicado en 2017

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups

artículo científico publicado en 2013

GIPR expression in gastric and duodenal neuroendocrine tumors

artículo científico publicado en 2014

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors

artículo científico publicado en 2013

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors

artículo científico publicado en 2014

Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide

artículo científico publicado en 2006

Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: Nine standard SEER registries, 1975–2006 ⬇️

artículo científico publicado el 1 de enero de 2011

MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

artículo científico publicado en 2005

Management of neuroendocrine tumors in children, adolescents, and young adults

artículo científico

Neuroendocrine tumors in children and young adults: rare or not so rare

scientific article published on March 2011

Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors

artículo científico publicado en 2013

Pancreastatin predicts survival in neuroendocrine tumors

artículo científico publicado en 2014

Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors

scientific article published on 16 September 2010

Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors

artículo científico publicado en 2013

Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells

artículo científico publicado en 2004

Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.

artículo científico publicado en 2002

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

artículo científico publicado en 2010

The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation

artículo científico publicado en 2008

The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma

artículo científico publicado en 2002

Two-career families: published data and personal reflections

artículo científico publicado en 2003

Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors

artículo científico publicado en 2008

VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice

artículo científico publicado en 2003

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

artículo científico publicado en 2016

When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?

artículo científico publicado en 2009

Lista de obras de Sue O'Dorisio

"Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system

2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells

90Y-edotreotide for metastatic carcinoid refractory to octreotide

A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon

Age-dependent levels of plasma neuropeptides in normal children

Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children

Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling

Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups

GIPR expression in gastric and duodenal neuroendocrine tumors

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors

Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide

Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: Nine standard SEER registries, 1975–2006 ⬇️

MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

Management of neuroendocrine tumors in children, adolescents, and young adults

Neuroendocrine tumors in children and young adults: rare or not so rare

Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors

Pancreastatin predicts survival in neuroendocrine tumors

Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors

Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors

Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells

Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1.

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation

The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma

Two-career families: published data and personal reflections

Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors

VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?